Financhill
Back

Zoetis Quote, Financials, Valuation and Earnings

Zoetis Price Quote

$164.76
-0.08 (0.76%)
(Updated: December 21, 2024 at 5:55 AM ET)

Zoetis Key Stats

Sell
38
Zoetis (ZTS) is a Sell

Day range:
$163.53 - $166.39
52-week range:
$144.80 - $200.53
Dividend yield:
1.05%
P/E ratio:
32.51
P/S ratio:
8.23
P/B ratio:
14.21%

Volume:
6.1M
Avg. volume:
2.7M
1-year change:
-15.31%
Market cap:
$74.4B
Revenue:
$8.5B
EPS:
$5.32

How Much Does Zoetis Make?

Data Unavailable

Is Zoetis Growing As A Company?

Data Unavailable

Zoetis Stock Price Performance

  • Did Zoetis Stock Go Up Last Month?
    Zoetis share price went down by -6.17% last month
  • Did ZTS's Share Price Rise Over The Last Year?
    ZTS share price fell by -15.31% over the past 1 year

What Is Zoetis 52-Week High & Low?

  • What Is Zoetis’s 52-Week High Share Price?
    Zoetis has traded as high as $200.53 over the past 52 weeks
  • What Is Zoetis’s 52-Week Low Share Price?
    Zoetis has traded as low as $144.80 over the past 52 weeks

Zoetis Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Zoetis?

Data Unavailable

Is Zoetis Cash Flow Positive?

Data Unavailable

Zoetis Return On Invested Capital

Data Unavailable

Zoetis Earnings Date & Stock Price

  • What Is Zoetis's Stock Price Today?
    A single share of ZTS can be purchased today for 164.84
  • What Is Zoetis’s Stock Symbol?
    Zoetis trades on the S&P500 under the ticker symbol: ZTS
  • When Is Zoetis’s Next Earnings Date?
    The next quarterly earnings date for Zoetis is scheduled on February 13, 2025
  • When Is ZTS's next ex-dividend date?
    Zoetis's next ex-dividend date is January 21, 2025
  • How To Buy Zoetis Stock?
    You can buy Zoetis shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Zoetis Competitors

  • Who Are Zoetis's Competitors?
    Below is a list of companies who compete with Zoetis or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Pfizer Inc (PFE)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Vertex Pharmaceuticals Inc (VRTX)

Zoetis Dividend Yield

Data Unavailable

Zoetis Analyst Estimates

YoY Growth Past Surprise
EPS: 16.28% 8.03%
Revenue: 11.02% 4.16%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 214.22
Upside from Last Price: 29.95%

Major Shareholders

Data Unavailable